GAS5 and osteosarcoma: GAS5 was downregulated in osteosarcoma tissues compared with that in adjacent normal group (Fig. 1A), among which the levels of GAS5 were further suppressed in osteosarcoma tissues obtained from DDP-resistant patients (Fig. 1B).